- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07842913
Hybrid Telerehabilitation for Anterior Knee Pain in Routine Physiotherapy Practice
Integrating Hybrid Telerehabilitation Into Routine Physiotherapy Practice for Anterior Knee Pain: Protocol for a Real-World Pragmatic Mixed-Methods Study
This study will examine how hybrid telerehabilitation is used in routine physiotherapy care for adults with anterior knee pain. Approximately 30 participants will be followed for 72 weeks while receiving individualized treatment from their physiotherapist, supported by the moveUP mobile application. The application provides prescribed exercises, educational information, communication with the physiotherapist, and progress monitoring.
The study will assess adherence to rehabilitation, pain, knee function, quality of life, psychological factors, and physical activity. It will also explore whether patient adherence and physiotherapist engagement are associated with clinical outcomes. Interviews with patients and healthcare professionals will examine barriers and facilitators to using the platform in routine care.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Miguel Farraj, PhD candidate
- Numéro de téléphone: +32494035113
- E-mail: miguel.farraj@ulb.be
Lieux d'étude
-
-
-
Brussels, Belgique
- Recrutement
- Private clinics
-
Contact:
- Miguel Farraj, PhD candidate
- Numéro de téléphone: +32494035113
- E-mail: miguel.farraj@ulb.be
-
-
-
-
-
Paris, France
- Recrutement
- Private clinics
-
Contact:
- Miguel Farraj, PhD candidate
- Numéro de téléphone: +32494035113
- E-mail: miguel.farraj@ulb.be
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Age 18 years or older.
- Clinical diagnosis of anterior knee pain, including patellofemoral pain, patellar tendinopathy, Hoffa's fat pad syndrome, chondromalacia, or femoropatellar, tibiopatellar, or tibiofemoral osteoarthritis not requiring surgery.
- Access to a smartphone compatible with the moveUP application.
Exclusion Criteria:
- Currently awaiting spine or lower-limb surgery.
- Lower-limb surgery or other invasive intervention within the previous two years.
- Joint prosthesis.
- Acute trauma to the trunk or lower limbs, or fracture, dislocation, or other musculoskeletal pathology of the affected lower limb within the previous six months.
- Saphenous nerve neuritis or Ehlers-Danlos syndrome.
- Severe osteoarthritis requiring joint replacement, systemic inflammatory joint disease (including rheumatoid arthritis or gout), or joint infection.
- Persistent low back pain lasting three months or longer.
- Vascular, respiratory, or neurological conditions that interfere with participation.
- Cognitive or psychiatric impairment limiting application use or communication.
- Pregnancy.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Hybrid Telerehabilitation
Participants receive individualized physiotherapy for anterior knee pain supported by the moveUP mobile application over 72 weeks. Treatment is prescribed and adapted by the treating physiotherapist according to individual patient needs. |
Hybrid telerehabilitation combining routine physiotherapy with the moveUP mobile application for adults with anterior knee pain. The platform supports individualized exercise prescription, educational modules, patient-physiotherapist communication, and progress monitoring. Exercise selection, frequency, and progression are determined by the treating physiotherapist according to patient needs. Participants are followed for 72 weeks. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Exercise Adherence (ATEMPT Score)
Délai: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
Exercise adherence will be assessed using the Adherence to Exercise for Musculoskeletal Pain Tool (ATEMPT). Total scores range from 6 to 30, with higher scores indicating greater adherence. |
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
|
Pain Intensity (Visual Analog Scale)
Délai: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
Pain intensity will be measured using a 0-100 mm Visual Analog Scale (VAS), where 0 indicates no pain and 100 indicates the worst pain imaginable. Higher scores indicate greater pain intensity. |
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Knee Function (Anterior Knee Pain Scale)
Délai: aseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
The Anterior Knee Pain Scale assesses symptoms and functional limitations associated with anterior knee pain. The total score ranges from 0 to 100, with higher scores indicating better function and fewer symptoms |
aseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
|
Health-Related Quality of Life (EQ-5D)
Délai: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
Health-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level (EQ-5D-5L) questionnaire. Responses will be converted into a utility index using the Belgian value set. Scores range from -0.532 to 1, with higher scores indicating better health-related quality of life. |
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
|
Fear of Movement (Tampa Scale for Kinesiophobia)
Délai: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
The 11-item Tampa Scale for Kinesiophobia assesses fear of movement or reinjury. The total score ranges from 11 to 44, with higher scores indicating greater kinesiophobia and therefore a worse outcome |
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
|
Pain Catastrophizing (Pain Catastrophizing Scale)
Délai: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
The Pain Catastrophizing Scale is a 13-item questionnaire assessing catastrophic thoughts related to pain. The total score ranges from 0 to 52, with higher scores indicating greater pain catastrophizing and therefore a worse outcome |
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
|
Physical Activity (Daily Step Count)
Délai: Daily/weekly
|
Daily/weekly
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- AIM2-AKP-001
- 2024-RDIR-5c (Autre subvention/numéro de financement: Innoviris)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .